AU2023361985B2 - A vvn001-containing ophthalmic composition - Google Patents

A vvn001-containing ophthalmic composition

Info

Publication number
AU2023361985B2
AU2023361985B2 AU2023361985A AU2023361985A AU2023361985B2 AU 2023361985 B2 AU2023361985 B2 AU 2023361985B2 AU 2023361985 A AU2023361985 A AU 2023361985A AU 2023361985 A AU2023361985 A AU 2023361985A AU 2023361985 B2 AU2023361985 B2 AU 2023361985B2
Authority
AU
Australia
Prior art keywords
sodium
acid
ophthalmic
composition
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2023361985A
Other languages
English (en)
Other versions
AU2023361985A1 (en
Inventor
Hongyan Gao
Qiao HAN
Yangqingqin LU
Wang Shen
Erning Xia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vivavision Biotech Ltd
Original Assignee
Vivavision Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivavision Biotech Ltd filed Critical Vivavision Biotech Ltd
Publication of AU2023361985A1 publication Critical patent/AU2023361985A1/en
Application granted granted Critical
Publication of AU2023361985B2 publication Critical patent/AU2023361985B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2023361985A 2023-04-27 2023-05-25 A vvn001-containing ophthalmic composition Active AU2023361985B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202310476403.2A CN118892446A (zh) 2023-04-27 2023-04-27 一种含vvn001的眼科组合物
CN202310476403.2 2023-04-27
PCT/CN2023/096273 WO2024221527A1 (zh) 2023-04-27 2023-05-25 一种含vvn001的眼科组合物

Publications (2)

Publication Number Publication Date
AU2023361985A1 AU2023361985A1 (en) 2024-11-14
AU2023361985B2 true AU2023361985B2 (en) 2025-08-14

Family

ID=93255459

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023361985A Active AU2023361985B2 (en) 2023-04-27 2023-05-25 A vvn001-containing ophthalmic composition

Country Status (9)

Country Link
EP (1) EP4702974A1 (https=)
JP (1) JP2025516407A (https=)
KR (1) KR20240159657A (https=)
CN (1) CN118892446A (https=)
AU (1) AU2023361985B2 (https=)
CA (1) CA3238321A1 (https=)
IL (1) IL312531A (https=)
TW (1) TW202442220A (https=)
WO (1) WO2024221527A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019001171A1 (zh) * 2017-06-27 2019-01-03 维眸生物科技上海有限公司 一种含磷化合物及其制备和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0589020A4 (en) * 1992-03-18 1994-07-06 Coopervision Pharma Verapamil hcl formulation and other ophthalmic solutions with buffer system for ocular administration
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
HUE059052T2 (hu) * 2014-11-07 2022-10-28 Santen Pharmaceutical Co Ltd Vizes szemészeti készítmény
CN109134533B (zh) * 2017-06-27 2020-08-11 维眸生物科技（上海）有限公司 一种含磷化合物及其制备和应用
CN114533652B (zh) * 2018-09-25 2024-12-13 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法和用途
US20230172946A1 (en) * 2019-08-18 2023-06-08 Iview Therapeutics, Inc. In-situ Gel Forming Ophthalmic Formulations Containing Difluprednate
IT202000027155A1 (it) * 2020-11-12 2022-05-12 Sifi Spa Formulazione a base di poliesametilene biguanide per il trattamento della cheratite da acanthamoeba
PL4312986T3 (pl) * 2021-04-01 2025-02-17 Active Biotech Ab Preparat lakwinimodu do stosowania do oczu

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019001171A1 (zh) * 2017-06-27 2019-01-03 维眸生物科技上海有限公司 一种含磷化合物及其制备和应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
QIU RUIQI, INFLAMMATION., PLENUM PRESS, NEW YORK, NY., US, vol. 44, no. 2, 16 November 2020 (2020-11-16), US , pages 780 - 794, XP037393034, ISSN: 0360-3997, DOI: 10.1007/s10753-020-01377-9 *
TAUBER JOSEPH, OCULAR SURFACE, vol. 28, 1 April 2023 (2023-04-01), pages 18 - 24, XP093228296, ISSN: 1542-0124, DOI: 10.1016/j.jtos.2022.12.007 *

Also Published As

Publication number Publication date
TW202442220A (zh) 2024-11-01
EP4702974A1 (en) 2026-03-04
JP2025516407A (ja) 2025-05-30
CN118892446A (zh) 2024-11-05
AU2023361985A1 (en) 2024-11-14
KR20240159657A (ko) 2024-11-05
CA3238321A1 (en) 2025-07-08
IL312531A (en) 2024-11-01
WO2024221527A1 (zh) 2024-10-31

Similar Documents

Publication Publication Date Title
US12491183B2 (en) Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
AU2023248145B2 (en) Ophthalmic suspension composition
US4966773A (en) Topical ophthalmic compositions containing microfine retinoid particles
CA1311418C (en) Eyedrops
RU2563125C2 (ru) Водные фармацевтические композиции, содержащие комплексы боратполиол
US4826871A (en) Topical ophthalmic compositions containing one or more retinoids
US5830913A (en) Method for preventing or treating dry eye or disease caused therefrom
US10517869B2 (en) Topical brimonidine tartrate ophthalmic solution
HU207950B (en) Process for producing pharmaceutical eye-drop composition
DE69323202T2 (de) Ophthalmologische zubereitungen
JP2015101582A (ja) 眼科用組成物
US20030031718A1 (en) Ophthalmic compositions and use
AU2023361985B2 (en) A vvn001-containing ophthalmic composition
JP2003128585A (ja) 外用組成物
JP2024501425A (ja) 眼炎症の有害作用を軽減するためのジフルプレドナート
KR20230145458A (ko) 우르소데옥시콜산 또는 그 염을 함유하는 수성 의약 조성물
US20230218611A1 (en) Ophthalmic compositions comprising a combination of brinzolamide and brimonidine
EP4230193A1 (en) Ophthalmic pharmaceutical composition
AU2023316921B2 (en) Ophthalmic composition for treating non-infectious inflammatory diseases
JP2025516407A5 (https=)
JP2022001606A (ja) エピナスチン又はその塩を含有する水性組成物
EP0342396A1 (en) Ophthalmic ointments for the treatment of glaucoma, comprising ergot alkaloids
RU2820596C2 (ru) Композиции оксиметазолина и способы для лечения офтальмологических расстройств
HK40113077A (zh) 一种含vvn001的眼科组合物
WO2024034592A1 (ja) Ｕｄｃａまたはその塩を含有する水性医薬組成物

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)